Home Cart Sign in  
Chemical Structure| 830-96-6 Chemical Structure| 830-96-6

Structure of 3-Indolepropionic acid
CAS No.: 830-96-6

Chemical Structure| 830-96-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

3-Indolepropionic Acid is a potent neuroprotective antioxidant and has potential in the treatment for Alzheimer’s disease. It's a gut microbial metabolite.

Synonyms: Indole-3-propionic acid; 3-IPA; VP-20629

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 3-Indolepropionic acid

CAS No. :830-96-6
Formula : C11H11NO2
M.W : 189.21
SMILES Code : C1=CC=CC2=C1C(=C[NH]2)CCC(O)=O
Synonyms :
Indole-3-propionic acid; 3-IPA; VP-20629
MDL No. :MFCD00005660
InChI Key :GOLXRNDWAUTYKT-UHFFFAOYSA-N
Pubchem ID :3744

Safety of 3-Indolepropionic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H315-H319-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary mouse hepatic stellate cells 50 µM 24 h To assess the effects of IPA on primary hepatic stellate cell activation, results showed that IPA significantly increased the mRNA expression of hallmark genes of HSC activation. Biomolecules. 2023 Sep 28;13(10):1464
LX-2 human hepatic stellate cells 10 µM and 50 µM 24 h To evaluate the direct effects of IPA on hepatic stellate cell activation, results showed that IPA upregulated the expression of fibrogenic marker genes and promoted features associated with HSCs activation, including proliferation and contractility. Biomolecules. 2023 Sep 28;13(10):1464
Enteric glial cells (EGCs) 0.1 μM 72 h Inhibited EGC activation, reduced expression of GFAP and SOX-10, decreased mRNA expression of inflammatory genes IL-6, IL-1β, and TNF-α, and protein expression of iNOS and COX-2. Acta Pharm Sin B. 2025 Apr;15(4):2024-2038

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice DSS-induced colitis model Oral gavage 200 mg/kg Once daily from Day 6 to Day 11 To investigate the protective effect of IPA on DSS-induced colitis, results showed that IPA pretreatment ameliorated DSS-induced decrease in growth performance, intestinal damage, and enhanced immunity in mice. Front Immunol. 2022 Sep 8;13:1014881
Mice Diabetic mouse model Intraperitoneal injection 10 mg/kg Once daily for 14 days Administration of 3-indolepropionic acid (IPA) significantly improved cognitive function and insulin sensitivity in diabetic mice, enhanced mitochondrial biogenesis, and protected synaptic ultrastructure. Nat Commun. 2020 Feb 18;11(1):855
C57BL/6J mice Rotenone-induced Parkinson's disease model Oral 25, 50, 100 mg/kg Once daily for 6 weeks Improved motor coordination, alleviated neuropathological damage, increased the number of TH-positive neurons, elevated dopamine content in the striatum, improved intestinal barrier function, and reduced inflammation. Acta Pharm Sin B. 2025 Apr;15(4):2024-2038
Sprague-Dawley rats Traumatic colon injury model Oral 10 mg/kg Daily administration from 14 days before modeling until the end of the experiment or rat death Oral administration of 3-indolepropionic acid (IPA) effectively prolonged the survival time of rats with traumatic colon injury and restored intestinal homeostasis. Mil Med Res. 2022 Jul 6;9(1):37

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.29mL

1.06mL

0.53mL

26.43mL

5.29mL

2.64mL

52.85mL

10.57mL

5.29mL

 

Historical Records

Categories